74773-17-4

Upstream product

• 85002-52-4 4-<2-(2-pyridyl)ethoxy>nitrobenzene 
• 350-46-9 4-Fluoronitrobenzene 
• 344561-49-5 4-[2-(2-pyridinyl)ethoxy]phenylamine 
• 103-74-2 2-(2-Hydroxyethyl)pyridine 
• 85003-44-7 2-Chloro-3-[4-(2-pyridin-2-yl-ethoxy)-phenyl]-propionic acid methyl ester 
• 17356-08-0 thiourea 

Relevant academic research and scientific papers

PROCESS FOR THE PREPARATION OF PIOGLITAZONE

The present invention relates to a new polymorphic form of 5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl thiazolidine-2,4-dione of Formula I, commonly known as pioglitazone. It also relates to processes for the preparation of new polymorphic form of pioglitazo

Pyridine N-oxide compounds which are useful as hypoglycemic and hypolipidemic agents

There is disclosed a novel thiazolidinedione derivative of the general formula (I): STR1 wherein R1 and R2 are the same or different and are a hydrogen atom or a lower alkyl group, or a salt thereof. The thiazolidinedione derivative has hypoglycemic activity and hypolipidemic activity.